1-7 of 7
Pablo E. Pergola
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease

Subject Area:
Nephrology
Pablo E. Pergola, Diogo Belo, Paul Crawford, Moustafa Moustafa, Wenli Luo, Alexander Goldfarb-Rumyantzev, Youssef M.K. Farag
Journal: American Journal of Nephrology
Am J Nephrol (2021) 52 (7): 572–581.
https://doi.org/10.1159/000516012
Published Online: 22 July 2021
View article titled, Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease
Open the PDF for Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease in another window
Journal Articles

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

Subject Area:
Nephrology
Glenn M. Chertow, Gerald B. Appel, Sharon Andreoli, Sripal Bangalore, Geoffrey A. Block, Arlene B. Chapman, Melanie P. Chin, Keisha L. Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A. Inker, Bertrand Knebelmann, Laura H. Mariani, Colin J. Meyer, Kandai Nozu, Megan O’Grady, Arnold L. Silva, Peter Stenvinkel, Roser Torra, Bradley A. Warady, Pablo E. Pergola
Journal: American Journal of Nephrology
Am J Nephrol (2021) 52 (3): 180–189.
https://doi.org/10.1159/000513777
Published Online: 31 March 2021
View article titled, Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Open the PDF for Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome in another window
Journal Articles

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Subject Area:
Nephrology
Melanie P. Chin, George L. Bakris, Geoffrey A. Block, Glenn M. Chertow, Angie Goldsberry, Lesley A. Inker, Hiddo J.L. Heerspink, Megan O’Grady, Pablo E. Pergola, Christoph Wanner, David G. Warnock, Colin J. Meyer
Journal: American Journal of Nephrology
Am J Nephrol (2018) 47 (1): 40–47.
https://doi.org/10.1159/000486398
Published Online: 18 January 2018
View article titled, Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Open the PDF for Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study in another window
Journal Articles

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Subject Area:
Nephrology
Matthew R. Weir, Pablo E. Pergola, Rajiv Agarwal, Jeffrey C. Fink, Nelson P. Kopyt, Ajay K. Singh, Jayant Kumar, Susanne Schmitt, Gregor Schaffar, Anita Rudy, Jim P. McKay, Radmila Kanceva
Journal: American Journal of Nephrology
Am J Nephrol (2017) 46 (5): 364–370.
https://doi.org/10.1159/000481736
Published Online: 30 October 2017
View article titled, A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease
Open the PDF for A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease in another window
Journal Articles

Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study

Subject Area:
Nephrology
Pablo E. Pergola, David M. Spiegel, Suzette Warren, Jinwei Yuan, Matthew R. Weir
Journal: American Journal of Nephrology
Am J Nephrol (2017) 46 (4): 323–332.
https://doi.org/10.1159/000481270
Published Online: 11 October 2017
View article titled, Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study
Open the PDF for Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study in another window
Journal Articles

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)

Subject Area:
Topic Article Package: Diabetes , Nephrology
Dick de Zeeuw, Tadao Akizawa, Rajiv Agarwal, Paul Audhya, George L. Bakris, Melanie Chin, Melissa Krauth, Hiddo J. Lambers Heerspink, Colin J. Meyer, John J. McMurray, Hans-Henrik Parving, Pablo E. Pergola, Giuseppe Remuzzi, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, David G. Warnock, Janet Wittes, Glenn M. Chertow
Journal: American Journal of Nephrology
Am J Nephrol (2013) 37 (3): 212–222.
https://doi.org/10.1159/000346948
Published Online: 28 February 2013
View article titled, Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
Open the PDF for Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) in another window
Journal Articles

Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD

Subject Area:
Topic Article Package: Diabetes , Nephrology
Pablo E. Pergola, Melissa Krauth, J. Warren Huff, Deborah A. Ferguson, Stacey Ruiz, Colin J. Meyer, David G. Warnock
Journal: American Journal of Nephrology
Am J Nephrol (2011) 33 (5): 469–476.
https://doi.org/10.1159/000327599
Published Online: 21 April 2011
View article titled, Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
Open the PDF for Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD in another window